5333332026-04-012026-06-305333332026-04-012026-06-30in-capmkt:OtherExpenses1Memberiso4217:INRxbrli:pureiso4217:INRxbrli:shares533333FCLNOTLISTEDINE045J01034FINEOTEX CHEMICAL LIMITEDMain BoardEquity2026-04-012027-03-312026-07-232026-07-16INRLakhsQuarterlyFirst quarterSingle segmentTextile specialty chemicals2026-07-2315:50:002026-07-2317:00:00Not applicable2026-04-012026-06-30UnauditedConsolidated3766277000100889000386716600024831460000-5086800026832000010100004388800047424300032197390006474270000647427000168998000-3624000165374000048205300000004820530005750004826280003839770009807700038455200098077000116450100010.410.41000.410.410001. The above consolidated results were reviewed and recommended by the Audit Committee and approved at the meeting of the Board of Directors of the Company held on 23rd July, 2026. The above results have been subjected to Limited Review by the Statutory Auditors of the Company. The Statutory Auditors have expressed an unqualified report on the above results. <br /> <br /> 2. This Statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. <br /> <br /> 3. These financial results together with the results of previous period have been prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 Interim Financial Reporting prescribed under Section 133 of the companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. <br /> <br /> 4. The figures of preceding quarter (i.e., three months ended March 31, 2026) are the balancing figures between the audited figure in respect of the full financial year and the published year to date figures upto the end of third quarter of the preceding financial year, which have been subject to limited review. <br /> <br /> 5. The Board of directors of the Company at their meeting held on Friday , 15th May , 2026 recommended a final divided of Rs. 0.05/- per equity share of face value of Rs. 1/- each, for the financial year ended 31st March, 2026. Final Dividend is Subject to approval of Shareholders. <br /> <br /> 6. The Company mainly operates in a single primary business segment of Speciality Chemicals, therefore disclosure requirements as per Ind AS 108, "Operating Segments" are not applicable to the Company. <br /> <br /> 7. Previous periods figure have been regrouped, rearranged, reclassified wherever necessary to correspond with those of the current period. <br /> <br /> 8. The Notes on the above results were approved at the meeting of the Board of Directors of the Company held on 23rd July, 2026. <br /> <br /> 9. The legal dispute concerning the Assignment Agreement for the property under 'Assets Held for Sale' had not been settled as of June 30, 2026 <br /> As of June 30, 2026, the company has paid Rs. 625.00 lakhs towards the settlement of the dispute. <br /> During Quarter 4 of the previous year, the company entered into a Memorandum of Understanding (MOU) with a third party for the transfer/assignment of the aforementioned Property Held for Sale. As of June 30, 2026, the company has received a total advance of Rs.1,008.00 lakhs ( Rs.800.00 lakhs in Q4 of the previous year and Rs.208.00 lakhs in the current quarter) <br /> As the transfer of the property had not been completed by 30 June 2026, the sale has not been recognised. Other Expenses474243000-5750000575000